Read the latest news and updates from NCATS.

Is this email not displaying correctly?
View it in your browser.

National Center for Advancing Translational Sciences | Catalyzing Innovation
Volume 05 • Issue 09 • September 29, 2016

Director's Message

Director's photo

Just five years ago, the idea of engineering a human-body-on-a-chip to predict drug safety and efficacy seemed more like science fiction than reality. But today, NCATS’ Tissue Chip for Drug Screening program, a collaborative initiative launched in 2012...


Connect with NCATS


Top Story

Zika Researcher running tests

NCATS Collaboration Advances Potential Zika Treatments

NCATS researchers recently tested and identified several commercially available compounds that can potentially inhibit Zika virus replication and reduce its ability to kill brain cells. These compounds now can be studied by the broader research community to help combat the Zika public health crisis. Read the NIH press release >

Twitter logo

Cheng-ting “Jason” Tsai and Peter Robinson prepare a gel electrophoreresis experiment to analyze a DNA-tagged biomarker

CTSA Program Supports New Ultrasensitive Diagnostic Test Development

Stanford University researchers, supported in part through NCATS’ Clinical and Translational Science Awards (CTSA) Program, have developed a new test for diagnosing diseases including thyroid cancer, HIV and type 1 diabetes. The method could potentially detect illnesses earlier, enabling clinicians to treat patients sooner and possibly slow disease progression. Read more >

Twitter logo

Scan of human brain

NCATS Offers New Repurposing Funding Opportunity

NCATS recently announced a new Bench-to-Clinic Repurposing initiative and related funding opportunity. The goal is to support investigators to repurpose ― or identify new uses for — existing experimental drugs or biologics as well as Food and Drug Administration-approved therapies already on the market. Read more >

Twitter logo

2015 NCATS Annual Report cover art

NCATS Issues 2015 Annual Report

NCATS’ 2015 annual report features major milestones, achievements, innovations and collaborations, all of which can help get more treatments to more patients more quickly. Read the 2015 NCATS Annual Report >

Twitter logo

Portraits of Dr. David Maloney and Samantha Jonson

Meet More NCATS Staff

David J. Maloney, Ph.D., is a chemistry team leader in NCATS’ Division of Pre-Clinical Innovation. Samantha G. Jonson, M.P.S., is an operations manager in NCATS’ Division of Clinical Innovation. Learn more about these and other staff members via NCATS Staff Profiles >

Twitter logo



NCATS’ Drs. Austin, Groft to speak at Intl. Conf. on Rare Diseases & Orphan Drugs.


Assay Guidance Manual workshop on high-throughput screening and lead discovery.

Research Opportunities and Announcements Highlights

More From NCATS

NCATS in the News

like us on Facebook |  follow us on Twitter |  forward to a friend |  watch us on YouTube

National Center for Advancing Translational Sciences
National Institutes of Health
6701 Democracy Boulevard, 9th Floor
Bethesda, MD 20892

For language access assistance, contact
the NCATS Public Information Officer.

Add us to your address book | Unsubscribe
NIH, National Center for Advancing Translational Sciences